BWA
53
-2
LLY
37
-7
NDAQ
59
-4
TROW
54
3
BMY
63
2
R
75
-2
CHRW
65
-2
TDC
73
2
DE
39
3
ORCL
68
-3
HPE
48
-22
QCOM
57
2
XRX
37
3
SPG
60
-3
MTCH
30
8
HBI
56
-2
AAL
59
2
IBM
50
-3
SYY
41
-6
PCG
94
-5
BWA
53
-2
LLY
37
-7
NDAQ
59
-4
TROW
54
3
BMY
63
2
R
75
-2
CHRW
65
-2
TDC
73
2
DE
39
3
ORCL
68
-3
HPE
48
-22
QCOM
57
2
XRX
37
3
SPG
60
-3
MTCH
30
8
HBI
56
-2
AAL
59
2
IBM
50
-3
SYY
41
-6
PCG
94
-5
Financhill
Back

AnaptysBio 10K Form

Sell
21

ANAB
AnaptysBio

Last Price:
19.25
Seasonality Move:
24.05%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-02 10Q ANAB/AnaptysBio Quarterly
2023-08-07 10Q ANAB/AnaptysBio Quarterly
2023-05-11 10Q ANAB/AnaptysBio Quarterly
2022-11-08 10Q ANAB/AnaptysBio Quarterly
2022-08-08 10Q ANAB/AnaptysBio Quarterly
2022-05-04 10Q ANAB/AnaptysBio Quarterly

Receive ANAB News And Ratings

See the #1 stock for the next 7 days that we like better than ANAB

ANAB Financial Statistics

Sales & Book Value

Annual Sales: $17.16M
Cash Flow: $-10.13M
Price / Cash Flow: 0
Annual Sales: $2.77
Price / Book: 7.27

Profitability

EPS (TTM): -6.08000
Net Income (TTM): $-165.66M
Gross Margin: $5.48M
Return on Equity: -236.31%
Return on Assets: -36.55%

AnaptysBio Earnings Forecast

Key AnaptysBio Financial Ratios

  • The Gross Profit Margin over the past 1 years for ANAB is 100.00%.
  • The Selling, General & Administrative Expenses for ANAB have been equal to 244.48% of Gross Profit Margin.
  • The Research & Development expenses have been 771.01% of Revenue.
  • The Interest Expense is -11.05% of Operating Income.
  • The Net Earning history of ANAB is -953.66% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 3 years.

AnaptysBio Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ANAB
CUSIP: 032724
Website: anaptysbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 10.23
Quick Ratio: 10.08

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ANAB Technical Analysis vs Fundamental Analysis

Sell
21
AnaptysBio (ANAB) is a Sell

Is AnaptysBio a Buy or a Sell?

  • AnaptysBio stock is rated a Sell
    The current AnaptysBio [ANAB] share price is $20.17. The Score for ANAB is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.